Sign in
CompletedNo phase

Genicular Nerve Block in Chronic Knee Osteoarthritis

Key facts

Who runs it
Haydarpasa Numune Training and Research Hospital
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
81 people enrolled
Started
1 Apr 2023
Ended
1 Jul 2024
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Genicular nerve block with prilocaine
  • genicular nerve block with prilocaine and triamcinolone
  • Sham injection
Record updated
28 November 2025

Who can take part

Age
45 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • age between 45 and 75
  • diagnosed with knee osteoarthritis (OA) according to the American College of Rheumatology (ACR) criteria
  • possessing a Kellgren-Lawrence radiological grade of 2-3

Who cannot take part

  • physical therapy for the target knee within the last 3 months
  • previous knee surgery
  • inflammatory rheumatic diseases
  • neurological disorders (e.g., Alzheimer's or dementia)
  • uncontrolled cardiopulmonary diseases
  • active malignancy
  • any joint injection to the target knee in the past 3 months
  • active lumbar radiculopathy on the same side
  • pregnancy or lactation
  • obesity (body mass index [BMI] >35)
  • presence of a pacemaker

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to evaluate whether genicular nerve block (GNB) is effective in reducing pain in patients with knee osteoarthritis. It will also assess the comparative efficacy of different injection protocols.

Read full original descriptionShow less

The main questions it aims to answer are:

Does genicular nerve block with corticosteroid and local anesthetic provide superior pain relief compared with local anesthetic alone or placebo?

Are there differences in clinical outcomes between the three treatment groups?

Researchers will compare three groups:

GNB with corticosteroid plus local anesthetic

GNB with local anesthetic alone

Sham procedure with saline (placebo control)

Participants will:

Receive the assigned injection protocol in accordance with their group

Be evaluated at baseline and scheduled follow-up visits for pain intensity and functional status

Report their pain scores and functional limitations using standardized assessment tools

The 3 groups in the trial

  • genicular nerve block with local anestheticExisting treatment, for comparison

    Group 1 (GNB with local anesthetic only): Patients received a genicular nerve block (GNB) with 6 mL of 2% prilocaine and participated in a knee exercise program.

    Treatment: Genicular nerve block with prilocaine

  • genicular nerve block with local anesthetic and corticosteroidExisting treatment, for comparison

    Group 2 (GNB with local anesthetic and corticosteroid): Patients received GNB with 5 mL of 2% prilocaine in combination with 1 mL/40 mg of triamcinolone and followed the same exercise regimen.

    Treatment: genicular nerve block with prilocaine and triamcinolone

  • sham injection with salineSham treatment, for comparison

    Group 3 (Control group): Patients received a placebo injection (6 mL of 0.9% saline) with the knee exercise program.

    Treatment: Sham injection

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effectiveness of Genicular Nerve Block on Pain and Disability in Chronic Knee Osteoarthritis: A Randomized Controlled Trial
Record updated
28 November 2025